Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus
|
|
|
- Curtis Lester
- 6 years ago
- Views:
Transcription
1 Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus
2 The contaminated area in the Republic of Belarus consisted of 3600 settlements (including 27 cities), where 2.2 million people lived. Currently, there live about 1.5 million people related to the affected population.
3 Radiation affected population monitoring; Obtaining the reliable data on the medical and biological effects of the Chernobyl accident; Provision of information to support dispensary examination, planning and carrying out therapeutic measures.
4 Maintenance of a personalized automated records of persons affected by the accident; Dynamic replenishment of necessary information about the persons affected by the accident; Development of normative-legal acts for the medical monitoring of the various categories of the affected citizens.
5 1 GPR - persons who participated in the liquidation of the Chernobyl accident and its consequences, divided into two subgroups 2 GPR persons evacuated or who left the areas of evacuation on their own in 1986; 3 GPR people living or working in the areas of primary and subsequent resettlement, as well as those who were resettled or who left these areas after the accident on their own; 4 GPR - persons born from people of 1-3groups, except for children belonging to the 2 and 3 groups; 5 GPR - people living or working in areas with the right of resettlement and of periodic radiation monitoring, as well as residents of other settlements, where the average equivalent radiation dose exceeds 1 msv per year. 6 GPR - persons who participated in the liquidation or affected by the accidents and their consequences at other nuclear facilities of civil or military purposes, as well as the victims of these accidents or as a result of trials, tests or other work related to nuclear facilities, including nuclear weapons; 7 GPR disabled people due to the Chernobyl NPP accident from the number of people who have no status affected due to the Chernobyl NPP accident, as well as children and adolescents upon detection of diseases of blood-forming organs (acute leukemia), thyroid gland (adenoma, cancer) and malignant tumors if they are not assigned to other groups of primary accounting.
6 GPR Total number UnderObservation at Number of Cancer Cases ( ) 1GPR (Liquidators) GPR (Evacuees) GPR (Residents) GPR (Offspring)
7 Total Children
![[ПРОЦЕНТ] [ПРОЦЕНТ] [ПРОЦЕНТ]](/docs-images/76/73321409/images/8-2.jpg "Brest Region [ПРОЦЕНТ] Gomel")
8 Minsk Region Grodno Region Minsk city [ПРОЦЕНТ] Mogilev Region [ПРОЦЕНТ] [ПРОЦЕНТ] [ПРОЦЕНТ] Brest Region [ПРОЦЕНТ] Gomel Region [ПРОЦЕНТ]
9 n Residents Liquidators Offspring Evacuees
10 Median of Age, years Liquidators Evacuees Residents Offspring
11 Per Birth Rate Mortality Rate Birth Rate Belarus Mortality Rate Belarus
12 Per (World standard) Belarus Liquidators Evacuees Residents
13 Affected Belarus 6.9% 8.0% 59.5% 8% 10% 56% 9.4% 12% 16.1% Cardiovascular diseases 14% Neoplasm Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Injury, poisoning and certain other consequences of external causes
14 Affected Diseases of the respiratory system Belarus 9.1% 26.9 % 49.8 % Cardiovascular diseases 10% 25% Diseases of the musculoskeletal system and connective tissue 52% 4.0% 5.9% 4.2% Diseases of the skin and subcutaneous tissue 5% 5% 3% Injury, poisoning and certain other consequences of external causes Other
15 From 1986 to 2014 the number of registered cases of cancer in Belarus increased from to (2 times)
16 In general there were many speculations, assumptions and predictions about the role of Chernobyl accident in cancer growth in Belarus. Most assumptions have been varying with the time. And till the present the question about role of Chernobyl accident has not been answered. But the growth of Thyroid cancer has been evident.
17 From 1978 to 2014 the number of registered cases of cancer in Belarus increased from to GR=3,4% a year GR=3,3% a year
18 Rate per population Rate per population Stomach (males) Stomach (females) Lip (males) The left scale is for incidence rates of stomach cancer (males, females). The right scale is for incidence rates of lip cancer. Years
19 Rate per population Lip (females) 4.00 Esophageas (females) Larynx (females) 3.00 Lung (females) 2.00 Pancreatic (females) 1.00 Liver (females) Urinary bladder (females) 0.00 Years
20 Rate per population Colon (males) Colon (females) Melanoma (males) Melanoma (females) Rate per population Corpus uteri Kidney (females) Breast The right scale is for incidence rates of breast cancer. The left scale is for all presented sites Years
21 Rate per population Esophageas (males) Rectal (males) Pancreatic (males) Rate per population Larynx (males) Thyroid (males) Ovaries Rectal (females) Urinary bladder (males) Lung (мужчины) The right scale is for incidence rates of lung cancer (males). The left scale is for all presented sites Years
22 Rate per population Skin (males) Rate per population Skin(females) Kidney (males) Prostate Thyroid (females) Years
23 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Chronic lymphatic leukaemia (C91.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C90 Multiple myeloma C81 Hodgkin lymphoma C73 Thyroid C71 Brain C67 Bladder C64 Kidney C62 Testis C61 Prostate C56 Ovary C54 Corpus uteri C53 Cervix uteri C50 Breast (MALES) C50 Breast (FEMALES) C45 Mesothelioma C44 Other skin C43 Melanoma of skin C40-41 Bone C33-34 Trachea, bronchus and lung C32 Larynx C25 Pancreas C23-24 Gallbladder etc. C22 Liver C20 Rectum C19 Rectosigmoid junction C18 Colon C16 Stomach C15 Oesophagus C12-13 Hypopharynx C11 Nasopharynx C07-08 Salivary glands C03-06 Mouth C01-02 Tongue C00 Lip
24 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Chronic lymphatic leukaemia (C91.1) cute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C90 Multiple myeloma C81 Hodgkin lymphoma C73 Thyroid C71 Brain C67 Bladder C64 Kidney C62 Testis C61 Prostate C56 Ovary C54 Corpus uteri C53 Cervix uteri C50 Breast (MALES) C50 Breast (FEMALES) C45 Mesothelioma C44 Other skin C43 Melanoma of skin C40-41 Bone C33-34 Trachea, bronchus and lung C32 Larynx C25 Pancreas C23-24 Gallbladder etc. C22 Liver C20 Rectum C19 Rectosigmoid junction C18 Colon C16 Stomach C15 Oesophagus C12-13 Hypopharynx C11 Nasopharynx C07-08 Salivary glands C03-06 Mouth C01-02 Tongue C00 Lip
25 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Chronic lymphatic leukaemia (C91.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C90 Multiple myeloma C81 Hodgkin lymphoma C73 Thyroid C71 Brain C67 Bladder C64 Kidney C62 Testis C61 Prostate C56 Ovary C54 Corpus uteri C53 Cervix uteri C50 Breast (MALES) C50 Breast (FEMALES) C45 Mesothelioma C44 Other skin C43 Melanoma of skin C40-41 Bone C33-34 Trachea, bronchus and lung C32 Larynx C25 Pancreas C23-24 Gallbladder etc. C22 Liver C20 Rectum C19 Rectosigmoid junction C18 Colon C16 Stomach C15 Oesophagus C12-13 Hypopharynx C11 Nasopharynx C07-08 Salivary glands C03-06 Mouth C01-02 Tongue C00 Lip
26 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Chronic lymphatic leukaemia (C91.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C90 Multiple myeloma C81 Hodgkin lymphoma C73 Thyroid C71 Brain C67 Bladder C64 Kidney C62 Testis C61 Prostate C56 Ovary C54 Corpus uteri C53 Cervix uteri C50 Breast (MALES) C50 Breast (FEMALES) C45 Mesothelioma C44 Other skin C43 Melanoma of skin C40-41 Bone C33-34 Trachea, bronchus and lung C32 Larynx C25 Pancreas C23-24 Gallbladder etc. C22 Liver C20 Rectum C19 Rectosigmoid junction C18 Colon C16 Stomach C15 Oesophagus C12-13 Hypopharynx C11 Nasopharynx C07-08 Salivary glands C03-06 Mouth C01-02 Tongue C00 Lip
27 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Chronic lymphatic leukaemia (C91.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C90 Multiple myeloma C81 Hodgkin lymphoma C73 Thyroid C71 Brain C67 Bladder C64 Kidney C62 Testis C61 Prostate C56 Ovary C54 Corpus uteri C53 Cervix uteri C50 Breast (MALES) C50 Breast (FEMALES) C45 Mesothelioma C44 Other skin C43 Melanoma of skin C40-41 Bone C33-34 Trachea, bronchus and lung C32 Larynx C25 Pancreas C23-24 Gallbladder etc. C22 Liver C20 Rectum C19 Rectosigmoid junction C18 Colon C16 Stomach C15 Oesophagus C12-13 Hypopharynx C11 Nasopharynx C07-08 Salivary glands C03-06 Mouth C01-02 Tongue C00 Lip
28 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C81 Hodgkin lymphoma C73 Thyroid C71 Brain C69 Eye C67 Bladder C64 Kidney C62 Testis C43 Melanoma of skin C22 Liver C20 Rectum C07-08 Salivary glands
29 PER All Adults (14+ years at diag.) Children (0-14 years at diag.) YEARS
30 Incidence rates of thyroid cancer by age groups (0-19) female (per )
31 Incidence rates of thyroid cancer by age groups (0-19) female (per )
32 Incidence rates of thyroid cancer by age groups (0-19) female (per )
33 Incidence rates of thyroid cancer by age groups (0-19) females (per ) They were born in
34 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C81 Hodgkin lymphoma C73 Thyroid C71 Brain C69 Eye C67 Bladder C64 Kidney C62 Testis C43 Melanoma of skin C22 Liver
35 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C81 Hodgkin lymphoma C73 Thyroid C71 Brain C69 Eye C67 Bladder C64 Kidney C62 Testis C43 Melanoma of skin C22 Liver C20 Rectum C07-08 Salivary glands
36 Leukaemia (С91-С95) Chronic myeloid leukaemia (C92.1, C93.1, C94.1) Acute myeloid leukaemia (C92.0, C93.0, C94.0, C94.2, C94.4-C94.5) Acute lymphatic leukaemia (C91.0) Non-Hodgkin lymphoma (C82.0-C85.9, C96) С00-С96 All malignant C81 Hodgkin lymphoma C73 Thyroid C71 Brain C69 Eye C67 Bladder C64 Kidney C62 Testis C43 Melanoma of skin C22 Liver C20 Rectum C07-08 Salivary glands
37 Thyroid Cancer Incidence
38 The contamination of the territory of Belarus with iodine-131 (reconstruction) estimated 10 May, 1986
39 SIR Liquidators Evaquees Residents
40 Per APC=0,3% в год Brest region Vitebsk region Gomel region Grodno region Minsk region Minsk city Mogilev region Belarus
41 Liquidators Evacuees Residents Offspring
42 Liquidators Evacuees Residents Offspring
43 Liquidators Evacuees Residents
44 Liqudators Evacuees Residents Offspring
45 Liquidators Evacuees Residents Offspring
46 SIR Liquidators Evacuees Residents
47 THANK YOU FOR YOUR ATTENTION
Cancer survival in Seoul, Republic of Korea,
Cancer survival in Seoul, Republic of Korea, 1993 1997 Ahn YO and Shin MH Abstract The Seoul cancer registry was established in 1991. Cancer is a notifiable disease, and registration of cases is done by
APPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
Cancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
Cancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
Information Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
Cancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
ANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
Information Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
Cancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
Cancer in Central and South America BOLIVIA
Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers
National Cancer Statistics in Korea, 2014
National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored
CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
Epidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
S2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
Overview of 2009 Hong Kong Cancer Statistics
Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
Overview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
Florida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
CHAPTER 10 CANCER REPORT. Germaine Wong Kirsten Howard Jonathan Craig Stephen McDonald Jeremy Chapman
CHAPTER 10 CANCER REPORT Germaine Wong Kirsten Howard Jonathan Craig Stephen McDonald Jeremy Chapman CANCER REPORT ANZDATA Registry 2006 Report INTRODUCTION RISK OF CANCERS IN KIDNEY DISEASES Notification
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive
Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2014, Article ID 437971, 18 pages http://dx.doi.org/10.1155/2014/437971 Research Article Cancer Incidence in Egypt: Results of the National
Cancer Program Report 2014
Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167
Cancer in New Mexico 2017
Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description
Supplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
Cancer in New Mexico 2014
Cancer in New Mexico 2014 Please contact us! Phone: 505-272-5541 E-Mail: info@nmtr.unm.edu http://som.unm.edu/nmtr/ TABLE OF CONTENTS Introduction... 1 New Cases of Cancer: Estimated Number of New Cancer
Information Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
Trends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
THE CHERNOBYL ACCIDENT AND ITS CONSEQUENCES
THE CHERNOBYL ACCIDENT AND ITS CONSEQUENCES Мikhail.V. Malko Institute of Power Engineering National Academy of Sciences of Belarus Minsk, Republic of Belarus E-mail: mikhailvm@bas-net.by IPPNW Deutschland
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption
Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption X Dong, Y Ren, R Wilson, and K Zhang NAACCR 6-20-2017 Introduction
Cancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer
Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more
Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER
The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW
Chapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2014 334 Jefferson Avenue, Scranton,
Prediction of Cancer Incidence and Mortality in Korea, 2018
pissn 1598-2998, eissn 256 Cancer Res Treat. 218;5(2):317-323 Special Article https://doi.org/1.4143/crt.218.142 Open Access Prediction of Cancer Incidence and Mortality in Korea, 218 Kyu-Won Jung, MS
HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014
HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014 COMMISSION ON CANCER STANDARD 1.12 Hunt Cancer Institute Mission Statement To be first in the South Bay/Peninsula communities in the provision of quality
Cancer Incidence in New Jersey Implementation of the Year 2000 Population Standard
Cancer Incidence in New Jersey 1995-1999 Implementation of the Year 2000 Population Standard Prepared by: Stasia S. Burger, MS, CTR Judith B. Klotz, MS, DrPH Rachel Weinstein, MS, PhD Toshi Abe, MSW, CTR
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2018 334 Jefferson Avenue, Scranton,
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,
155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
CANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012
CANCER IN NSW ABORIGINAL PEOPLES Incidence, mortality and survival September 2012 CANCER IN NSW ABORIGINAL PEOPLES Contents Tables 1 Figures 2 Message from the Chief Cancer Officer 4 Executive summary
ALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
Selected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
Outcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
Overview of 2013 Hong Kong Cancer Statistics
Overview of 2013 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry (HKCaR) is a population-based cancer registry, collecting the basic demographic data, information
Cancer survival in Bhopal, India,
Chapter 13 Cancer survival in Bhopal, India, 1991 1995 Dikshit R, Kanhere S and Surange S Abstract The Bhopal population-based cancer registry was established in 1986 under the national cancer registry
ALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
Prediction of Cancer Incidence and Mortality in Korea, 2013
pissn 1598-2998, eissn 256 Cancer Res Treat. 213;45(1):15-21 Special Article http://dx.doi.org/1.4143/crt.213.45.1.15 Open Access Prediction of Cancer Incidence and Mortality in Korea, 213 Kyu-Won Jung,
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 Menzies Centre for Population Health Research University of Tasmania Tasmanian Cancer Registry 17 Liverpool
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)
Suicides increased in 2014
Causes of death 2014 23 May, 2016 Suicides increased in 2014 Diseases of the circulatory system accounted for 30.7% of the deaths recorded in 2014, 2.4% more than in the previous year. The average age
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
Transplantation and oncogenic risk: the role of viruses
Transplantation and oncogenic risk: the role of viruses VIM 2014, Katoomba Associate Professor Angela Webster angela.webster@sydney.edu.au What can transplantation help us understand about infection and
Cancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
Cancer Incidence in Sweden 1998
STATISTICS HEALTH AND DISEASES 2000:4 Cancer Incidence in Sweden 1998 CENTRE FOR EPIDEMIOLOGY SVERIGES OFFICIELLA STATISTIK OFFICIAL STATISTICS OF SWEDEN Statistics - Health and Diseases Cancer Incidence
Cancer in Ireland with estimates for
Cancer in Ireland 1994-2015 with estimates for 2015-2017: Annual Report of the National Cancer Registry 2017 Page ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
Cancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1-: Annual Report of the National Cancer Registry ABBREVIATIONS % CI % confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) CNS Central
Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India
DOI:10.22034/APJCP.2017.18.6.1485 RESEARCH ARTICLE Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India Aleyamma Mathew 1 *, Preethi Sara George 1, Kalavathy MC 1, Padmakumari
Cancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1994-213: Annual Report of the National Cancer Registry 215 Page 3 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard
Overview of Gynecologic Cancers in New Jersey
Overview of Gynecologic Cancers in New Jersey New Jersey State Cancer Registry Antoinette M. Stroup, PhD presented at: Gynecologic Cancer Symposium: Striving for a Healthier Tomorrow, Today November 19,
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Cancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
Cancer Survival in Wales, Goroesi Cancr yng Nghymru,
Cancer Survival in Wales, 1989-1998 Goroesi Cancr yng Nghymru, 1989-1998 Welsh Cancer Intelligence & Surveillance Unit Uned Arolygiaeth a Gwybodaeth Cancr Cymru DIRECTOR S INTRODUCTION I am pleased to
CANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
Does an occupation at a tannery promote pancreatic cancer? Investigate the possible relation between cancer mortality and tannery occupation.
2/4/212 N.N. lexandrov National Center of Belarus Does an occupation at a tannery promote pancreatic cancer? Ilya Veyalkin, PhD Minsk Tannery Enterprise is one of the biggest in the world. Many peoples
Samuel M. Lesko, MD, MPH Director of Research/Medical Director
Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984
Malignant Neoplasm Prevalence in the Aktobe Region of Kazakhstan
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.18.8149 RESEARCH ARTICLE Malignant Neoplasm Prevalence in the Aktobe Region of Kazakhstan Yerbol Bekmukhambetov 1, Arstan Mamyrbayev 2, Timur Jarkenov 3, Aliya
Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017
Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Presentation Overview Background Methods Results Conclusions 2 1 Background Increase physician reporting Capture missing first course treatment Capture
National level ICD 9-3 digit Nuts II european shortlist Croatia 1999/2000 From WHO ICD-10, 4 digit. 1999/2000 From WHO ICD-10, 4 digit
Gleb Denissov Reference Period Transmission to Eurostat Data Albania 1999/2000 From WHO ICD-9, 3 digit Bulgaria 1999/2000 National level from WHO Nuts II level by e-mail National level ICD 9-3 digit Nuts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent
Physician On-line Staging Application. Darlene Dale Head, PMH Cancer Registry
Physician On-line Staging Application Darlene Dale Head, PMH Cancer Registry NAACCR 2004 Outline Overview of Princess Margaret Hospital History of Staging at PMH Steps to On-Line Physician Staging at PMH
Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway
Cancer in Norway 7 Cancer incidence, mortality, survival and prevalence in Norway Special issue: Long-term cancer survival: patterns and trends in Norway 96-7 Cancer in Norway 7 Editor-in-chief: Freddie
Cancer in New Brunswick
Cancer in New Brunswick 2002-2006 Message from the New Brunswick Cancer Network (NBCN) Co-CEOs The New Brunswick Cancer Network is pleased to provide the Provincial Cancer Report 2002-2006. This is the
Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway
Cancer in Norway 2007 Cancer incidence, mortality, survival and prevalence in Norway Special issue: Long-term cancer survival: patterns and trends in Norway 1965-2007 Cancer in Norway 2007 Editor-in-chief:
5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
SKCC Protocol Review Committee New Study Application
Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score
Nov FromAtoZCodesMatter
Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray
CANCER REGISTRY Annual Report
CANCER REGISTRY Annual Report 2017 Cancer Treatment Centers of America at Southeastern Regional Medical Center Atlanta, Georgia Philadelphia, Pennsylvania Chicago, Illinois Tulsa, Oklahoma Phoenix, Arizona
ASSESSMENT OF CHERNOBYL MALIGNANT NEOPLASMS IN EUROPEAN COUNTRIES
ASSESSMENT OF CHERNOBYL MALIGNANT NEOPLASMS IN EUROPEAN COUNTRIES M.V. Malko Joint Institute of Power and Nuclear Research Sosny National Academy of Sciences of Belarus Krasin Str. 99, Minsk, 220109, Belarus.
All Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
Cancer Incidence and Mortality in Los Alamos County and New Mexico By Catherine M. Richards, M.S. 8
Cancer Incidence and Mortality in Los Alamos County and New Mexico 1970-1996 By Catherine M. Richards, M.S. 8 Introduction This report was written in response to community concerns about occurrences of
John R. Marsh Cancer Center
John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the
CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
Munich Cancer Registry
Munich Cancer Registry Survival Selection Matrix Homepage Deutsch ICD-10 C64: Kidney cancer Incidence and Mortality Year of diagnosis 1998-2016 Patients 11,292 Diseases 11,533 Creation date 08/21/2018
Hazelinks - Cancer incidence analysis (First data extraction)
Hazelinks - Cancer incidence analysis (First data extraction) Authors Prof Malcolm Sim Ms Christina Dimitriadis Dr Caroline Gao Mr Anthony Del Monaco 1 1 Contents Abbreviations... 3 Executive Summary...
Munich Cancer Registry
Munich Cancer Registry Survival Selection Matrix Homepage Deutsch ICD-10 C64-C68: Urinary tract cancer Incidence and Mortality Year of diagnosis 1998-2016 Patients 23,443 Diseases 24,423 Creation date
TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA,
TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA, 1950-1997 - TOTAL LIVE FETAL INFANT NEONATAL MATERNAL DEATHS BIRTHS DEATHS DEATHS DEATHS DEATHS ----------------------------------------------------------------------------------